Janumet XR 100mg/1000mg Tablets

Manufacturer MERCK Active Ingredient Sitagliptin and Metformin Extended-Release Tablets(sit a GLIP tin & met FOR min) Pronunciation JAN-oo-met EKS-AR (sit-a-GLIP-tin & met-FOR-min)
WARNING: Rarely, metformin may cause too much lactic acid in the blood (lactic acidosis). The risk is higher in people who have kidney problems, liver problems, heart failure, use alcohol, or take certain other drugs, including topiramate. The risk is also higher in people who are 65 or older and in people who are having surgery, an exam or test with contrast, or other procedures. If lactic acidosis happens, it can lead to other health problems and can be deadly. Kidney tests may be done while taking this drug.Do not take this drug if you have a very bad infection, low oxygen, or a lot of fluid loss (dehydration).Call your doctor right away if you have signs of too much lactic acid in the blood (lactic acidosis) like confusion; fast breathing; fast or slow heartbeat; a heartbeat that does not feel normal; very bad stomach pain, upset stomach, or throwing up; feeling very sleepy; shortness of breath; feeling very tired or weak; very bad dizziness; feeling cold; or muscle pain or cramps. @ COMMON USES: It is used to help control blood sugar in people with type 2 diabetes.
đŸˇī¸
Drug Class
Antidiabetic, Oral
đŸ§Ŧ
Pharmacologic Class
Dipeptidyl Peptidase-4 (DPP-4) Inhibitor and Biguanide Combination
🤰
Pregnancy Category
Category C
✅
FDA Approved
Jan 2012
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Janumet XR is a medication used to help control blood sugar levels in adults with type 2 diabetes. It contains two medicines: sitagliptin, which helps your body make more insulin when blood sugar is high and reduces sugar made by the liver, and metformin, which helps your body use insulin better and reduces the amount of sugar your liver makes. It's an extended-release tablet, meaning the medicine is released slowly over time.
📋

How to Use This Medicine

Taking Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. Take your medication with a meal, preferably in the evening, unless your doctor advises otherwise. Swallow the tablet whole; do not chew, break, or crush it. Continue taking your medication as directed by your doctor or healthcare provider, even if you start feeling well.

Storing and Disposing of Your Medication

Store all products at room temperature in a dry location, avoiding bathrooms. Keep your medication in a safe place, out of reach of children and pets, to prevent accidental ingestion.

Missing a Dose

If you miss a dose, take it as soon as you remember, with food. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
💡

Lifestyle & Tips

  • Take Janumet XR once daily with your evening meal to reduce stomach upset and improve absorption.
  • Swallow the tablet whole; do not crush, chew, or break it.
  • Follow a healthy diet plan recommended by your doctor or dietitian.
  • Engage in regular physical activity as advised by your healthcare provider.
  • Limit or avoid alcohol consumption, as it can increase the risk of a serious side effect called lactic acidosis.
  • Stay well-hydrated, especially during exercise or in hot weather.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Initial: Sitagliptin 50 mg/Metformin XR 500 mg once daily with the evening meal. Titrate gradually to minimize gastrointestinal side effects. Maintenance: Sitagliptin 100 mg/Metformin XR 1000 mg or 100 mg/2000 mg once daily with the evening meal.
Dose Range: 50 - 2000 mg

Condition-Specific Dosing:

maximumDailyDose: Sitagliptin 100 mg / Metformin 2000 mg (as XR formulation)
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: eGFR 45-59 mL/min/1.73 m2: Max Metformin XR 1000 mg daily. Max Sitagliptin 50 mg daily. Janumet XR 50 mg/500 mg or 50 mg/1000 mg may be used.
Moderate: eGFR 30-44 mL/min/1.73 m2: Max Metformin XR 1000 mg daily. Max Sitagliptin 25 mg daily. Janumet XR is not recommended; individual components should be used to achieve appropriate dosing.
Severe: eGFR < 30 mL/min/1.73 m2: Contraindicated.
Dialysis: Contraindicated in patients on dialysis.

Hepatic Impairment:

Mild: No dose adjustment for sitagliptin. Metformin should be used with caution.
Moderate: Metformin is generally not recommended due to increased risk of lactic acidosis. Sitagliptin no specific adjustment.
Severe: Contraindicated due to metformin component (increased risk of lactic acidosis).

Pharmacology

đŸ”Ŧ

Mechanism of Action

Janumet XR combines two antihyperglycemic agents with complementary mechanisms of action to improve glycemic control in patients with type 2 diabetes mellitus: Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Metformin, a biguanide. Sitagliptin works by inhibiting the inactivation of incretin hormones (GLP-1 and GIP) by DPP-4, thereby increasing their active levels. This leads to glucose-dependent increases in insulin synthesis and release from pancreatic beta cells and decreases in glucagon secretion from pancreatic alpha cells. Metformin acts by decreasing hepatic glucose production, decreasing intestinal absorption of glucose, and improving insulin sensitivity by increasing peripheral glucose uptake and utilization.
📊

Pharmacokinetics

Absorption:

Bioavailability: Sitagliptin: Approximately 87%; Metformin XR: Approximately 50-60% (relative to immediate-release, can vary with food)
Tmax: Sitagliptin: 1-4 hours; Metformin XR: 4-8 hours
FoodEffect: Sitagliptin: No clinically meaningful effect; Metformin XR: Food increases the extent of absorption and prolongs Tmax.

Distribution:

Vd: Sitagliptin: Approximately 198 L; Metformin: 654 Âą 358 L
ProteinBinding: Sitagliptin: Approximately 79%; Metformin: Negligible
CnssPenetration: Sitagliptin: Limited; Metformin: Limited

Elimination:

HalfLife: Sitagliptin: Approximately 12.4 hours; Metformin: Plasma elimination half-life is approximately 6.2 hours, blood half-life is approximately 17.6 hours
Clearance: Sitagliptin: Primarily renal; Metformin: Primarily renal
ExcretionRoute: Sitagliptin: Renal (79% unchanged); Metformin: Renal (primarily unchanged)
Unchanged: Sitagliptin: 79%; Metformin: >90%
âąī¸

Pharmacodynamics

OnsetOfAction: Sitagliptin: Within hours; Metformin: Days to weeks for full effect
PeakEffect: Sitagliptin: Within 1-4 hours; Metformin: 4-8 hours (Tmax for XR)
DurationOfAction: Sitagliptin: Approximately 24 hours; Metformin: Approximately 24 hours (XR formulation)

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Postmarketing cases of lactic acidosis, a serious metabolic complication, have been reported with metformin use and can result in death. The risk of lactic acidosis is increased with renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors), age 65 years or greater, radiological studies with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure), excessive alcohol intake, and hepatic impairment. If lactic acidosis is suspected, Janumet XR should be discontinued immediately and supportive measures initiated. Healthcare professionals should counsel patients against excessive alcohol intake while receiving Janumet XR and inform them about the symptoms of lactic acidosis and conditions that predispose to it.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following signs or symptoms, contact your doctor or seek medical attention immediately:

Allergic Reaction: Rash, hives, itching, red, swollen, blistered, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat.
Kidney Problems: Inability to pass urine, changes in urine output, blood in the urine, or significant weight gain.
Low Blood Sugar: Dizziness, headache, feeling sleepy or weak, shaking, fast heartbeat, confusion, hunger, or sweating. If you experience any of these symptoms, follow your doctor's instructions for managing low blood sugar, which may include taking glucose tablets, liquid glucose, or consuming certain fruit juices.
Stomach Problems: If you experience stomach issues later in treatment, such as upset stomach, vomiting, or diarrhea, contact your doctor right away, as this could be a sign of lactic acidosis (a blood acid health problem).
Pancreatitis: Severe and potentially life-threatening pancreas problems can occur at any time during treatment. Warning signs include severe stomach pain, severe back pain, or severe upset stomach or vomiting.
Severe Skin Reaction (Stevens-Johnson Syndrome): This rare but potentially life-threatening condition can cause severe health problems and death. Seek medical help immediately if you experience red, swollen, blistered, or peeling skin (with or without fever), red or irritated eyes, or sores in your mouth, throat, nose, or eyes.
Joint Pain: If you experience severe or persistent joint pain, contact your doctor right away.
Bullous Pemphigoid: A skin reaction that can cause blisters or skin breakdown. Seek medical help immediately if you notice any of these symptoms.
Heart Failure: If you have a history of heart failure or kidney problems, inform your doctor. Contact your doctor right away if you experience extreme fatigue, shortness of breath, significant weight gain, or swelling in the arms or legs.

Other Side Effects

Most people do not experience significant side effects, but some may occur. If you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical attention:

Stomach pain or heartburn
Diarrhea, upset stomach, or vomiting
Gas
Feeling tired or weak
Headache
Signs of a common cold
Nose or throat irritation

Reporting Side Effects

If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • **Lactic Acidosis (SERIOUS):** Unusual muscle pain, trouble breathing, stomach discomfort, unusual tiredness, dizziness, lightheadedness, or feeling cold. Seek immediate medical attention.
  • **Pancreatitis (SERIOUS):** Severe stomach pain that does not go away, with or without vomiting. The pain may spread from your stomach to your back. Seek immediate medical attention.
  • **Hypoglycemia (Low Blood Sugar):** Sweating, shaking, fast heartbeat, dizziness, hunger, confusion, or irritability. More likely if used with insulin or sulfonylureas.
  • **Allergic Reactions:** Rash, hives, swelling of your face, lips, tongue, or throat, or difficulty breathing or swallowing. Seek immediate medical attention.
  • **Kidney Problems:** Changes in urination, swelling in your legs or feet.
  • **Joint Pain:** Severe and disabling joint pain.
  • **Bullous Pemphigoid:** Large, fluid-filled blisters on your skin.
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced.
If you have type 1 diabetes, as this medication is not intended to treat this condition.
Certain health conditions, including:
+ Acidic blood problems
+ Kidney disease
+ Liver disease
Recent heart attack or stroke
Any difficulties with eating or drinking normally, such as before undergoing a procedure or surgery

Additionally, if you are scheduled to have an exam or test that involves contrast media, or have had one within the past 48 hours, discuss this with your doctor.

To ensure your safety, it is crucial to provide your doctor and pharmacist with a comprehensive list of:

All medications you are currently taking, including prescription and over-the-counter drugs, natural products, and vitamins
* Any health problems you have

This information will help your doctor determine whether it is safe for you to take this medication with your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Regularly monitor your blood work and other lab tests as directed by your doctor.

Before consuming alcohol, discuss the potential risks with your doctor. Additionally, check your blood sugar levels as instructed by your doctor to ensure they are within a safe range. If your blood sugar levels are low, avoid driving, as this can increase your risk of being involved in an accident.

Be aware that stress, such as fever, infection, injury, or surgery, can affect your blood sugar control. Changes in physical activity, exercise, or diet can also impact your blood sugar levels. To maintain optimal blood sugar control, adhere to the diet and exercise plan recommended by your doctor.

In hot weather or during physical activity, drink plenty of fluids to prevent dehydration. If you are unable to consume liquids orally or experience persistent stomach upset, vomiting, or diarrhea, contact your doctor for guidance on preventing dehydration. Dehydration can lead to low blood pressure or worsen existing kidney problems.

Kidney problems are a potential side effect of this medication, and in some cases, hospitalization or dialysis may be necessary. Long-term treatment with metformin may cause low vitamin B-12 levels. If you have a history of low vitamin B-12 levels, consult your doctor.

If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. Women of childbearing age who have not been ovulating may experience a return of fertility while taking this medication. To avoid pregnancy, use birth control while taking this drug.

If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor. You and your doctor will need to discuss the potential benefits and risks of this medication to you and your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Lactic acidosis (severe)
  • Hypoglycemia (if co-administered with sulfonylurea or insulin)
  • Gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea, abdominal pain)

What to Do:

Call 1-800-222-1222 (Poison Control Center) immediately or seek emergency medical attention. Treatment is supportive. Hemodialysis can remove metformin and sitagliptin.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Iodinated contrast agents (temporarily discontinue Janumet XR at the time of or prior to the procedure and for 48 hours after)
  • Patients with metabolic acidosis, including diabetic ketoacidosis, acute or chronic, with or without coma
  • Severe renal impairment (eGFR < 30 mL/min/1.73 m2)
  • Acute or chronic conditions which may cause tissue hypoxia (e.g., cardiac or respiratory failure, recent myocardial infarction, shock)
  • Hepatic impairment (severe)
🔴

Major Interactions

  • Alcohol (potentiates metformin's effect on lactate metabolism, increasing risk of lactic acidosis)
  • Carbonic anhydrase inhibitors (e.g., topiramate, zonisamide, acetazolamide, dichlorphenamide) - may increase risk of lactic acidosis
  • Drugs that reduce metformin clearance (e.g., cimetidine, ranolazine, dolutegravir, isavuconazole, trimethoprim, vandetanib) - may increase metformin levels and risk of lactic acidosis
  • Other antidiabetic agents (e.g., sulfonylureas, insulin) - increased risk of hypoglycemia
🟡

Moderate Interactions

  • Corticosteroids, diuretics (thiazide and loop), phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blockers, isoniazid - may produce hyperglycemia, requiring dose adjustment of Janumet XR
  • Nifedipine - may increase metformin absorption
  • Furosemide - may increase metformin plasma and blood concentrations
đŸŸĸ

Minor Interactions

  • Not available

Monitoring

đŸ”Ŧ

Baseline Monitoring

Renal function (eGFR)

Rationale: To assess kidney function and determine appropriate dosing, as both sitagliptin and metformin are renally cleared and metformin is contraindicated in severe renal impairment.

Timing: Prior to initiation of therapy

HbA1c

Rationale: To establish baseline glycemic control and guide initial therapy.

Timing: Prior to initiation of therapy

Fasting Plasma Glucose (FPG)

Rationale: To establish baseline glucose levels.

Timing: Prior to initiation of therapy

📊

Routine Monitoring

Renal function (eGFR)

Frequency: At least annually; more frequently (e.g., every 3-6 months) in patients at risk for renal impairment (e.g., elderly, those with pre-existing renal disease)

Target: >60 mL/min/1.73 m2 for full dose; >45 mL/min/1.73 m2 for reduced dose

Action Threshold: Discontinue if eGFR falls below 30 mL/min/1.73 m2; adjust dose if eGFR falls below 45 mL/min/1.73 m2

HbA1c

Frequency: Every 3-6 months

Target: Individualized, typically <7%

Action Threshold: Consider therapy adjustment if target not met

Blood Glucose (FPG, postprandial)

Frequency: Daily or as directed by healthcare provider

Target: Individualized, typically FPG 80-130 mg/dL, postprandial <180 mg/dL

Action Threshold: Persistent hyperglycemia or hypoglycemia requires evaluation and potential dose adjustment

Vitamin B12 levels

Frequency: Periodically (e.g., every 1-2 years) in patients on long-term metformin therapy or those with risk factors for deficiency

Target: Normal range

Action Threshold: Supplement if deficiency is detected, especially if symptomatic (e.g., peripheral neuropathy)

đŸ‘ī¸

Symptom Monitoring

  • Symptoms of lactic acidosis (e.g., malaise, myalgia, respiratory distress, somnolence, abdominal distress)
  • Symptoms of pancreatitis (e.g., severe, persistent abdominal pain, radiating to the back, with or without vomiting)
  • Symptoms of hypoglycemia (e.g., sweating, tremor, dizziness, confusion, hunger, irritability) especially if used with sulfonylurea or insulin
  • Symptoms of hypersensitivity reactions (e.g., rash, urticaria, angioedema, anaphylaxis)
  • Symptoms of bullous pemphigoid (e.g., large, fluid-filled blisters on the skin)
  • Symptoms of joint pain (severe and disabling arthralgia)

Special Patient Groups

🤰

Pregnancy

Generally not recommended during pregnancy. Poorly controlled diabetes during pregnancy increases the risk of birth defects, pregnancy loss, and other complications. Insulin is generally preferred for glycemic control during pregnancy.

Trimester-Specific Risks:

First Trimester: Potential for increased risk of major birth defects with uncontrolled diabetes.
Second Trimester: Risk of adverse maternal and fetal outcomes with uncontrolled diabetes.
Third Trimester: Risk of adverse maternal and fetal outcomes with uncontrolled diabetes.
🤱

Lactation

Both sitagliptin and metformin are excreted into human milk. The decision to discontinue nursing or discontinue the drug should take into account the importance of the drug to the mother and the potential risks to the infant. Metformin is generally considered compatible with breastfeeding by some experts, but sitagliptin data is more limited.

Infant Risk: L3 (Moderately safe - limited data, possible risk)
đŸ‘ļ

Pediatric Use

Safety and effectiveness have not been established in pediatric patients under 18 years of age. Not recommended for use in this population.

👴

Geriatric Use

Use with caution in elderly patients due to the higher likelihood of decreased renal function. Renal function should be assessed more frequently in elderly patients. Increased risk of lactic acidosis with metformin in this population.

Clinical Information

💎

Clinical Pearls

  • Always take Janumet XR with the evening meal to minimize gastrointestinal side effects and optimize metformin XR absorption.
  • Swallow tablets whole; do not crush, chew, or break them, as this will disrupt the extended-release mechanism.
  • Patients may notice a tablet ghost (empty matrix) in their stool, which is normal and does not mean the medication was not absorbed.
  • Educate patients thoroughly on the symptoms of lactic acidosis and the importance of seeking immediate medical attention if they occur.
  • Temporarily discontinue Janumet XR before any radiological procedure involving iodinated contrast agents or any surgical procedure requiring restricted food and fluid intake.
  • Monitor renal function (eGFR) regularly, especially in elderly patients or those with risk factors for kidney impairment.
  • Be aware of the increased risk of hypoglycemia when Janumet XR is used in combination with insulin or sulfonylureas, and consider dose adjustments of those agents.
🔄

Alternative Therapies

  • Other oral antidiabetic agents (e.g., sulfonylureas, TZDs, SGLT2 inhibitors, GLP-1 receptor agonists, alpha-glucosidase inhibitors)
  • Insulin therapy
  • Lifestyle modifications (diet and exercise)
💰

Cost & Coverage

Average Cost: $400 - $600+ per 30 tablets (for 100mg/1000mg strength)
Generic Available: Yes
Insurance Coverage: Tier 2 or Tier 3 (Preferred or Non-Preferred Brand)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure your safety, never share your medication with others or take someone else's medication. This medication is accompanied by a Medication Guide, which provides crucial information for patients. Please read this guide carefully and review it again each time you receive a refill of this medication. If you have any questions or concerns about this medication, consult your doctor, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide details about the overdose, including the amount taken and the time it occurred.